Company profile for ReCerise Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ReCerise Therapeutics Inc. is a biotech company dedicated to developing targeted therapies for progressive liver diseases. With a strong focus on R&D-driven innovation, our team of experts in basic translation, medicinal research, and biotechnology is committed to advancing specialized treatments for diverse liver disease patients. We strive to secure proprietary technologies and drive breakthrough solutions, aiming to improve...
ReCerise Therapeutics Inc. is a biotech company dedicated to developing targeted therapies for progressive liver diseases. With a strong focus on R&D-driven innovation, our team of experts in basic translation, medicinal research, and biotechnology is committed to advancing specialized treatments for diverse liver disease patients. We strive to secure proprietary technologies and drive breakthrough solutions, aiming to improve patient outcomes and transform the landscape of liver disease treatment.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
#910/911/912/913, 400-12, Yangcheon-ro, Gangseo-gu, Seoul
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty